共 50 条
- [1] Course of Active Inflammatory and Fatty Lesions in Patients With Early Axial Spondyloarthritis Treated With Infliximab Plus Naproxen as Compared to Naproxen Alone: Results From the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (08) : 1899 - 1903
- [2] Description of Distribution of Active Inflammatory Lesions On Magnetic Resonance Imaging of the Sacroiliac Joints and the Spine in Patients with Early Axial Spondyloarthritis - Analysis of the Esther Trial baseline Data. [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S249 - S249
- [6] A Randomized, Open-Label Study of Maintenance of Partial Remission with Naproxen Vs No Treatment: Results of the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial, Part II. [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S239 - S239
- [8] Double-Blind, Placebo-Controlled, 28-Week Trial of Efficacy and Safety of Infliximab Plus Naproxen Vs Naproxen Alone: Results From the Infliximab As First Line Therapy in Patients with Early, Active Axial Spondyloarthritis Trial, Part I [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S588 - S589